FDA Approves First Liquid Biopsy NGS Companion Diagnostic
This is the first approval to combine two technologies—NGS and liquid biopsy—in one diagnostic in order to guide treatment decisions.
Read More
Search Results for: lung cancer
Liquid Biopsy Research Reveals New Insights on Genetic Changes in Cancer
Researchers used Menarini Silicon Biosystems’ liquid biopsy technology to learn more about genetic changes in circulating cancer cells.
Read More
Israel Expands Non-Small Cell Lung Cancer Testing Coverage
Israeli laboratories are approved to use molecular profiling assays for NSCLC patients using Thermo Fisher Scientific’s Oncomine Comprehensive Assay Plus.
Read More
Merus, Caris Life Sciences Collaborate to Detect NRG1 Fusions in Cancer Patients
Caris will provide DNA and RNA molecular testing to support patient identification and enrollment for Merus’ Zenocutuzumab Phase 1/2 eNRGy trial.
Read MoreGuardant Health, Janssen to Develop Liquid Biopsy Companion Diagnostic
The collaborators are pursuing regulatory approval of the Guardant360 CDx as a companion diagnostic for amivantamab for the treatment of NSCLC.
Read More